Completed OBSERVATIONAL NCT01109277

Prediction of Neonatal Hyperbilirubinemia (2010ICTPAGR)

An Evidence-based Strategy for Assessing the Risk of Significant Neonatal Hyperbilirubinemia

Sponsor: University of Patras

Updated 7 times since 2017 Last updated: Jan 18, 2011 Started: Apr 30, 2010 Primary completion: Jan 31, 2011 Completion: Jan 31, 2011

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

This observational or N/A phase trial investigates Hyperbilirubinemia, Neonatal and is currently completed. University of Patras leads this study, which shows 7 recorded versions since 2010 — indicating limited longitudinal coverage. The change history captured here reflects the iterative nature of clinical trial conduct.

Status Flow

Change History

7 versions recorded

Sep 2025 — Present [monthly]

Completed
Sep 2024 — Sep 2025 [monthly]

Completed
Jul 2024 — Sep 2024 [monthly]

Completed
Jan 2021 — Jul 2024 [monthly]

Completed
Jun 2018 — Jan 2021 [monthly]

Completed

▶ Show 2 earlier versions

Apr 2018 — Jun 2018 [monthly]

Completed

Phase: NA → None
Jan 2017 — Apr 2018 [monthly]

Completed NA

First recorded

Apr 2010

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

University of Patras

Data source: University of Patras

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Pátrai, Greece